- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02951507
Evaluation of Patient Satisfaction and Biting Force of New Design of Extracoronal Attachment (O T Cap Unilateral Attachment) Versus Conventional Partial Denture for Treatment of Unilateral Mandibular Distal Extension Area
October 31, 2016 updated by: Mohamed mamdouh afify, Cairo University
Comparison of new design of extra coronal castable precision attachment (OT unilateral attachment) and conventional partial denture in patient satisfaction and biting force.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
42
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with unilateral mandibular distal extension area
- Normal crown/root ratio of last premolar
- co-operative patients
Exclusion Criteria:
- completely edentulous patient
- few remaining teeth
- patients exposed to radiotherapy and chemotherapy
- patients with maxillary or mandibular defect
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional partial denture
Intervention will be O T unilateral attachment
|
O T unilateral attachment system
|
Active Comparator: Conventional removal partial denture
Intervention will be new design of extra coronal attachment( O T unilateral attachment)
|
O T unilateral attachment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient satisfaction
Time Frame: 12 months
|
OHIP-14 questionnaire
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Biting force
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2017
Primary Completion (Anticipated)
December 1, 2017
Study Registration Dates
First Submitted
October 29, 2016
First Submitted That Met QC Criteria
October 31, 2016
First Posted (Estimate)
November 1, 2016
Study Record Updates
Last Update Posted (Estimate)
November 1, 2016
Last Update Submitted That Met QC Criteria
October 31, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- CEBD-CU-2016-10-232
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Acceptance of Health Care
-
Hanoi Obstetrics and Gynecology HospitalMỹ Đức HospitalCompletedPatient Acceptance of Health CareVietnam
-
Malahat AmaniCompletedPatient Acceptance of Health CareIran, Islamic Republic of
-
Cukurova UniversityNot yet recruitingPatient Acceptance of Health Care | Drug Compliance
-
Nepal Mediciti HospitalCompletedSafety Issues | Patient Acceptance of Health CareNepal
-
Chiang Mai UniversityCompleted
-
University of ChicagoNational Institute of Mental Health (NIMH); ACCESS Community Health NetworkCompletedHIV | Patient Acceptance of Health CareUnited States
-
Medstar Health BaltimoreRecruitingHeart Failure | Patient Acceptance of Health CareUnited States
-
Fudan UniversityMerck Sharp & Dohme LLCWithdrawnData Collection | Machine Learning | Patient Acceptance of Health Care | Vaccination Refusal | Internet-Based Intervention | Immunization Programs | Information Dissemination | Social Medium
-
Cliniques universitaires Saint-Luc- Université...UnknownSkin Cancer | Patient Satisfaction | Patient Acceptance of Health Care
-
University of BernRecruitingTooth Loss | Patient Satisfaction | Patient Acceptance of Health Care | Bone Graft; ComplicationsSwitzerland
Clinical Trials on O T unilateral attachment
-
University of DelawareCompleted
-
West Virginia UniversityPenn State UniversityCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI); Mustang Bio, Inc.Active, not recruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Refractory Acute Myeloid Leukemia | Blastic Plasmacytoid Dendritic Cell Neoplasm | Minimal Residual Disease | Acute... and other conditionsUnited States
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
The Affiliated Hospital of Qingdao UniversityNot yet recruiting
-
Sumithira VasuRecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent High Grade... and other conditionsUnited States
-
Jonsson Comprehensive Cancer CenterParker Institute for Cancer ImmunotherapyRecruitingRecurrent Mantle Cell Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | CD20 Positive | Refractory Mantle Cell Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Refractory... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm OncologyCompletedAcute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Minimal Residual Disease | Small Lymphocytic Lymphoma | Acute Biphenotypic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia | CD19 Positive | Blasts 5 Percent or More of Bone Marrow Nucleated CellsUnited States
-
Crystal Mackall, MDRecruitingRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Philadelphia Chromosome Positive | Refractory Acute Lymphoblastic Leukemia | Minimal Residual Disease | CD19 PositiveUnited States